Microbicidal power of alpha radiation in sterilizing germinating Bacillus anthracis spores

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 3, 2014, Pages 1813-1815

  Rivera, Johanna ^a   Morgenstern, Alfred ^b   Bruchertseifer, Frank ^b   Kearney, John F ^c   Turnbough Jr , Charles L ^c   Dadachova, Ekaterina ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b JOINT RESEARCH CENTRE   (Italy)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH 213; EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY EA2 1 BISMUTH BI 213; UNCLASSIFIED DRUG;

ALPHA RADIATION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; BACTERICIDAL ACTIVITY; BINDING AFFINITY; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RADIATION STERILIZATION; RADIOIMMUNOTHERAPY; SPORE GERMINATION;

ALPHA PARTICLES; ANTIBODIES, MONOCLONAL; BACILLUS ANTHRACIS; BISMUTH; MICROSCOPY, PHASE-CONTRAST; RADIOISOTOPES; SPORES, BACTERIAL;

EID: 84896877101     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01266-13     Document Type: Article

References (26)

1. Spotts Whitney EA, Beatty ME, Taylor TH, Jr, Weyant R, Sobel J, Arduino MJ, Ashford DA. 2003. Inactivation of Bacillus anthracis spores. Emerg. Infect. Dis. 9:623-627. http://dx.doi.org/10.3201/eid0906.020377. (Pubitemid 36676354)
2. Milenic D, Garmestani K, Dadachova E, Chappell L, Albert P, Hill D, Schlom J, Brechbiel M. 2004. Radioimmunotherapy of human colon carcinoma xenografts using a 213Bi-labeled domain-deleted humanized monoclonal antibody. Cancer Biother. Radiopharm. 19:135-147. http://dx.doi.org/10.1089/ 108497804323071904. (Pubitemid 38685111)
3. Milenic DE, Brady ED, Brechbiel MW. 2004. Antibody-targeted radiation cancer therapy. Nat. Rev. Drug Discov. 3:488-499. http://dx.doi.org/10.1038/ nrd1413.
4. Dadachova E, Bryan RA, Apostolidis C, Morgenstern A, Zhang T, Moadel T, Torres M, Huang X, Revskaya E, Casadevall A. 2006. Interaction of radiolabeled antibodies with fungal cells and components of the immune system in vitro and during radioimmunotherapy for experimental fungal infection. J. Infect. Dis. 193:1427-1436. http://dx.doi.org/10.1086/503369. (Pubitemid 43673391)
5. Bryan RA, Jiang Z, Morgenstern A, Bruchertseifer F, Casadevall A, Dadachova E. 2013. Radioimmunotherapy of Cryptococcus neoformans spares bystander mammalian cells. Future Microbiol. 8:1081-1089. http://dx.doi.org/10. 2217/fmb.13.79.
6. Nosanchuk JD, Dadachova E. 2011. Radioimmunotherapy of fungal diseases: the therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens. Front. Microbiol. 2:283. http://dx.doi.org/10. 3389/fmicb.2011.00283.
7. Casadevall A, Goldstein H, Dadachova E. 2007. Targeting host cells harbouring viruses with radiolabeled antibodies. Exp. Opin. Biol. Ther. 7:595-597. http://dx.doi.org/10.1517/14712598.7.5.595.
8. Dadachova E, Wang XG, Casadevall A. 2007. Targeting the virus with radioimmunotherapy in virus-associated cancers. Cancer Biother. Radiopharm. 22:303-308. http://dx.doi.org/10.1089/cbr.2007.344. (Pubitemid 47067888)
9. Dadachova E, Burns T, Bryan RA, Apostolidis C, Brechbiel MW, Nosanchuk JD, Casadevall A, Pirofski L. 2004. Feasibility of radioimmunotherapy of experimental pneumococcal infection. Antimicrob. Agents Chemother. 48:1624-1629. http://dx.doi.org/10.1128/AAC.48.5.1624-1629.2004. (Pubitemid 38544367)
10. Dadachova E, Howell RW, Bryan RA, Frenkel A, Nosanchuk JD, Casadevall A. 2004. Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes. J. Nucl. Med. 45:313-320. (Pubitemid 47618656)
11. Rivera J, Nakouzi AS, Morgenstern A, Bruchertseifer F, Dadachova E, Casadevall A. 2009. Radiolabeled antibodies to Bacillus anthracis toxins are bactericidal and partially therapeutic in experimental murine anthrax. Antimicrob. Agents Chemother. 53:4860-4868. http://dx.doi.org/10.1128/AAC.01269- 08.
12. Collier RJ, Young JA. 2003. Anthrax toxin. Annu. Rev. Cell Dev. Biol. 19:45-70. http://dx.doi.org/10.1146/annurev.cellbio.19.111301.140655. (Pubitemid 37487342)
13. Driks A. 2009. The Bacillus anthracis spore. Mol. Aspects Med. 30:368-373. http://dx.doi.org/10.1016/j.mam.2009.08.001.
14. Swiecki MK, Lisanby MW, Shu F, Turnbough CL, Jr, Kearney JF. 2006. Monoclonal antibodies for Bacillus anthracis spore detection and functional analyses of spore germination and outgrowth. J. Immunol. 176:6076-6084.
15. Sylvestre P, Couture-Tosi E, Mock M. 2002. A collagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium. Mol. Microbiol. 45:169-178. http://dx.doi.org/10.1046/j.1365-2958.2000.03000.x. (Pubitemid 35025942)
16. Steichen C, Chen P, Kearney JF, Turnbough CL, Jr. 2003. Identification of the immunodominant protein and other proteins of the Bacillus anthracis exosporium. J. Bacteriol. 185:1903-1910. http://dx.doi.org/10.1128/JB.185.6. 1903-1910.2003. (Pubitemid 36297890)
17. Welkos SL, Cote CK, Rea KM, Gibbs PH. 2004. A microtiter fluorometric assay to detect the germination of Bacillus anthracis spores and the germination inhibitory effects of antibodies. J. Microbiol. Methods 56:253-265. http://dx.doi.org/10.1016/j.mimet.2003.10.019. (Pubitemid 38117184)
18. Welkos SL, Trotter RW, Becker DM, Nelson GO. 1989. Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice. Microb. Pathog. 7:15-35. http://dx.doi.org/10.1016/0882- 4010(89)90108-3. (Pubitemid 19228457)
19. Apostolidis C, Molinet R, Rasmussen G, Morgenstern A. 2005. Production of Ac-225 from Th-229 for targeted alpha therapy. Anal. Chem. 77:6288-6291. http://dx.doi.org/10.1021/ac0580114. (Pubitemid 41436964)
20. Dadachova E, Nakouzi A, Bryan RA, Casadevall A. 2003. Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection. Proc. Natl. Acad. Sci. U. S. A. 100:10942-10947. http://dx.doi.org/10.1073/pnas. 1731272100. (Pubitemid 37140132)
21. Nicholson WL, Munakata N, Horneck G, Melosh HJ, Setlow P. 2000. Resistance of Bacillus endospores to extreme terrestrial and extraterrestrial environments. Microbiol. Mol. Biol. Rev. 64:548-572. http://dx.doi.org/10.1128/ MMBR.64.3.548-572.2000.
22. Day J, Friedman A, Schlesinger LS. 2011. Modeling the host response to inhalation anthrax. J. Theor. Biol. 276:199-208. http://dx.doi.org/10.1016/j. jtbi.2011.01.054.
23. Lyons CR, Lovchik J, Hutt J, Lipscomb MF, Wang E, Heninger S, Berliba L, Garrison K. 2004. Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility. Infect. Immun. 72:4801-4809. http://dx.doi.org/10.1128/IAI.72.8.4801-4809.2004. (Pubitemid 38989340)
24. Friedlander AM, Welkos SL, Pitt MLM, Ezzell JW, Worsham PL, Rose KJ, Ivins BE, Lowe JR, Howe GB, Mikesell P, Lawrence LB. 1993. Postexposure prophylaxis against experimental inhalation anthrax. J. Infect. Dis. 167:1239-1243. http://dx.doi.org/10.1093/infdis/167.5.1239. (Pubitemid 23115626)
25. Gut IM, Tamilselvam B, Prouty AM, Stojkovic B, Czeschin S, van der Donk WA, Blanke SR. 2011. Bacillus anthracis spore interactions with mammalian cells: relationship between germination state and the outcome of in vitro. BMC Microbiol. 11:46. http://dx.doi.org/10.1186/1471-2180-11-46.
26. Henderson DW, Peacock S, Belton FC. 1956. Observations on the prophylaxis of experimental pulmonary anthrax in the monkey. J. Hyg. (Lond.) 54:28-36. http://dx.doi.org/10.1017/S0022172400044272.